Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Total Non-Current Liabilities (2022 - 2025)

Historic Total Non-Current Liabilities for Immunocore Holdings (IMCR) over the last 4 years, with Q3 2025 value amounting to $609.3 million.

  • Immunocore Holdings' Total Non-Current Liabilities fell 1342.32% to $609.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $609.3 million, marking a year-over-year decrease of 1342.32%. This contributed to the annual value of $648.8 million for FY2024, which is 18558.41% up from last year.
  • Latest data reveals that Immunocore Holdings reported Total Non-Current Liabilities of $609.3 million as of Q3 2025, which was down 1342.32% from $609.9 million recorded in Q2 2025.
  • In the past 5 years, Immunocore Holdings' Total Non-Current Liabilities ranged from a high of $703.8 million in Q3 2024 and a low of $185.6 million during Q4 2022
  • In the last 4 years, Immunocore Holdings' Total Non-Current Liabilities had a median value of $609.9 million in 2025 and averaged $540.7 million.
  • In the last 5 years, Immunocore Holdings' Total Non-Current Liabilities surged by 18558.41% in 2024 and then tumbled by 1342.32% in 2025.
  • Over the past 4 years, Immunocore Holdings' Total Non-Current Liabilities (Quarter) stood at $185.6 million in 2022, then grew by 22.37% to $227.2 million in 2023, then soared by 185.58% to $648.8 million in 2024, then fell by 6.08% to $609.3 million in 2025.
  • Its last three reported values are $609.3 million in Q3 2025, $609.9 million for Q2 2025, and $587.1 million during Q1 2025.